Paper2947744
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
Tarazi RC and 1 other. Circulation, 1987. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy? Papers, record 2947744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2947744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Cardiomegaly | Major topic |
| Animals | |
| Blood Pressure | |
| Coronary Circulation | |
| Heart | |
| Humans | |
| Myocardial Contraction | |
| Risk |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22826659 | Hypertension research program at ochsner: a program in translational research. | Ochsner J | 2002 | https://conductscience.org/library/papers/22826659 | PubMed |
| 8086328 | Modifications in peripheral hemodynamics and left ventricular function in hypertensives treated with nicardipine slow release. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/8086328 | PubMed |
| 7841088 | Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/7841088 | PubMed |
| 3254831 | Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension. | Drugs | 1988 | https://conductscience.org/library/papers/3254831 | PubMed |
| 3154670 | Correction of physiological alterations of hypertension. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154670 | PubMed |
| 3154632 | Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154632 | PubMed |
| 2969799 | Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans. | Drugs | 1988 | https://conductscience.org/library/papers/2969799 | PubMed |
| 2969798 | Effects of different antihypertensive drugs on left ventricular function. | Drugs | 1988 | https://conductscience.org/library/papers/2969798 | PubMed |
| 2535100 | Left ventricular mass changes with nicardipine therapy in essential hypertension. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2535100 | PubMed |
| 2535055 | Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2535055 | PubMed |
| 2275700 | 1,2-diacylglycerol content in myocardium from spontaneously hypertensive rats during the development of hypertension. | Basic Res Cardiol | 1990 | https://conductscience.org/library/papers/2275700 | PubMed |
| 1390327 | Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy. | Cardiovasc Drugs Ther | 1992 | https://conductscience.org/library/papers/1390327 | PubMed |
| 1381046 | Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension. | Mol Cell Biochem | 1992 | https://conductscience.org/library/papers/1381046 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2947744
GET https://conductscience.org/api/papers/v1/2947744/authors